Abstract
The proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa was examined by introducing the cloned wild-type Escherichia coli gyrA and gyrB genes. Of 101 spontaneous mutants of P. aeruginosa PAO505, 33 (33%) were found to have gyrA mutations. Among 17 clinical isolates, 12 (71%) had gyrA mutations and 1 (6%) had a gyrB mutation.
MeSH Terms
4-Quinolones
Anti-Infective Agents/pharmacology
DNA Topoisomerases, Type II/genetics
Drug Resistance, Microbial/genetics
Mutation
Pseudomonas aeruginosa/drug effects,genetics
Transformation, Genetic/physiology
Chemicals
4-Quinolones
Anti-Infective Agents
DNA Topoisomerases, Type II
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Yoshida H
Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
Nakamura M
Bogaki M
Nakamura S
References (17)
17 references, click to expand
-
Studies on the mechanism of action of nalidixic acid.
Antimicrob Agents Chemother. 1973 Oct;4(4):479-86
PMID: 4208771
-
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
J Bacteriol. 1969 Jul;99(1):238-41
PMID: 4895844
-
Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity.
Proc Natl Acad Sci U S A. 1978 Apr;75(4):1773-7
PMID: 347446
-
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
Antimicrob Agents Chemother. 1982 Aug;22(2):242-9
PMID: 6821455
-
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
Mol Gen Genet. 1986 Sep;204(3):367-73
PMID: 3020376
-
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53
PMID: 3532944
-
Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.
Antimicrob Agents Chemother. 1986 Nov;30(5):777-80
PMID: 3026239
-
Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.
J Bacteriol. 1987 May;169(5):2322-5
PMID: 3032915
-
Mechanisms of action of and resistance to ciprofloxacin.
Am J Med. 1987 Apr 27;82(4A):12-20
PMID: 3034057
-
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1987 Apr;31(4):582-6
PMID: 3111356
-
Quinolone-resistant mutations of the gyrA gene of Escherichia coli.
Mol Gen Genet. 1988 Jan;211(1):1-7
PMID: 2830458
-
Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
Antimicrob Agents Chemother. 1988 Apr;32(4):535-9
PMID: 2837141
-
Low- and intermediate-copy-number cloning vectors based on the Pseudomonas plasmid pVS1.
Antonie Van Leeuwenhoek. 1988;54(6):567-73
PMID: 3148293
-
gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.
Antimicrob Agents Chemother. 1989 Feb;33(2):254-5
PMID: 2655532
-
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
Antimicrob Agents Chemother. 1989 May;33(5):624-34
PMID: 2502066
-
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
Antimicrob Agents Chemother. 1986 Apr;29(4):639-44
PMID: 3010850
-
Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772-6
PMID: 337300